Literature DB >> 19597194

Creating access to health technologies in poor countries.

Laura J Frost1, Michael R Reich.   

Abstract

Many people in developing countries lack access to health technologies. We present seven findings about processes that shape access, based on analysis of six case histories: praziquantel to treat schistosomiasis (a parasitic worm disease), hepatitis B vaccine, the Norplant contraceptive, malaria rapid diagnostic tests, vaccine vial monitors, and the female condom. Each case study is assessed with a comprehensive framework that examines the effects of architecture, availability, affordability, and adoption on creating access. The analysis shows that access to health technology in poor countries is difficult to achieve because of multiple obstacles, but it can be created under certain conditions.

Entities:  

Mesh:

Year:  2009        PMID: 19597194     DOI: 10.1377/hlthaff.28.4.962

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  16 in total

1.  Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.

Authors:  N Abdel Rida; M I Mohamed Ibrahim; Z U D Babar
Journal:  BMC Health Serv Res       Date:  2019-12-18       Impact factor: 2.655

2.  Modeling structural, dyadic, and individual factors: the inclusion and exclusion model of HIV related behavior.

Authors:  Dolores Albarracin; Melanie B Tannenbaum; Laura R Glasman; Alexander J Rothman
Journal:  AIDS Behav       Date:  2010-12

Review 3.  Retail sector distribution chains for malaria treatment in the developing world: a review of the literature.

Authors:  Edith Patouillard; Kara G Hanson; Catherine A Goodman
Journal:  Malar J       Date:  2010-02-11       Impact factor: 2.979

4.  Development of and access to products for neglected diseases.

Authors:  Joshua Cohen; Maria Staroselsky Dibner; Andrew Wilson
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

5.  Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance.

Authors:  Ana Wheelock; Andreas B Eisingerich; Jintanat Ananworanich; Gabriela B Gomez; Timothy B Hallett; Mark R Dybul; Peter Piot
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

6.  Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study.

Authors:  Andreas B Eisingerich; Ana Wheelock; Gabriela B Gomez; Geoffrey P Garnett; Mark R Dybul; Peter K Piot
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

7.  Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions.

Authors:  Alan Brooks; Antoinette Ba-Nguz
Journal:  Health Policy Plan       Date:  2012-05       Impact factor: 3.344

8.  Technology-assisted stroke rehabilitation in Mexico: a pilot randomized trial comparing traditional therapy to circuit training in a Robot/technology-assisted therapy gym.

Authors:  Karla Bustamante Valles; Sandra Montes; Maria de Jesus Madrigal; Adan Burciaga; María Elena Martínez; Michelle J Johnson
Journal:  J Neuroeng Rehabil       Date:  2016-09-15       Impact factor: 4.262

9.  Where are the NGOs and why? The distribution of health and development NGOs in Bolivia.

Authors:  Lindsay P Galway; Kitty K Corbett; Leilei Zeng
Journal:  Global Health       Date:  2012-11-23       Impact factor: 4.185

10.  Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania.

Authors:  Idda Romore; Ritha J A Njau; Innocent Semali; Aziza Mwisongo; Antoinette Ba Nguz; Hassan Mshinda; Marcel Tanner; Salim Abdulla
Journal:  Malar J       Date:  2016-03-08       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.